Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. (6s)-1-(3,4-difluorophenyl)-6-(5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(4-methoxycyclohexyl)benzimidazol-2-yl)piperidin-2-one
2. Ccs-1477
3. Ccs1477
1. Ccs-1477
2. 2222941-37-7
3. Inobrodib [inn]
4. Inobrodib [usan]
5. Ccs1477
6. Bw5qa5gew7
7. Cbp-in-1
8. P300/cbp Bromodomain Inhibitor Ccs1477
9. (s)-1-(3,4-difluorophenyl)-6-(5-(3,5-dimethylisoxazol-4-yl)-1-((1r,4s)-4-methoxycyclohexyl)-1h-benzo[d]imidazol-2-yl)piperidin-2-one
10. (s)-1-(3,4-difluorophenyl)-6-(5-(3,5-dimethylisoxazol-4-yl)-1-(trans-4-methoxycyclohexyl)-1h-benzo[d]imidazol-2-yl)piperidin-2-one
11. (6s)-1-[3,4-bis(fluoranyl)phenyl]-6-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(4-methoxycyclohexyl)benzimidazol-2-yl]piperidin-2-one
12. (s)-1-(3,4-difluorophenyl)-6-(5-(3,5-dimethylisoxazol-4-yl)-1-((1r,4s)-4-methoxycyclohexyl)-1h-benzo(d)imidazol-2-yl)piperidin-2-one
13. 2-piperidinone, 1-(3,4-difluorophenyl)-6-(5-(3,5-dimethyl-4-isoxazolyl)-1-(trans-4-methoxycyclohexyl)-1h-benzimidazol-2-yl)-, (6s)-
14. 2-piperidinone, 1-(3,4-difluorophenyl)-6-[5-(3,5-dimethyl-4-isoxazolyl)-1-(trans-4-methoxycyclohexyl)-1h-benzimidazol-2-yl]-, (6s)-
15. Ccs1477; Inobrodib
16. Unii-bw5qa5gew7
17. Chembl4785363
18. Schembl20094038
19. Schembl21515367
20. Schembl22134021
21. Schembl23433835
22. Ccs-1477 [who-dd]
23. Ex-a3687
24. Nsc818619
25. S9667
26. Who 11833
27. Ccs-1477 (cbp-in-1)
28. Nsc-818619
29. Hy-111784
30. Cs-0091862
31. A930140
32. (6s)-1-(3,4-difluorophenyl)-6-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(4-methoxycyclohexyl)benzimidazol-2-yl]piperidin-2-one
33. (6s)-1-(3,4-difluorophenyl)-6-[5-(3,5-dimethyl-1,2-oxazol-4-yl)-1-(trans-4-methoxycyclohexyl)-1h-benzimidazol-2-yl]piperidin-2-one
34. (s)-1-(3,4-difluorophenyl)-6-(5-(3,5-dimethylisoxazol-4-yl)-1-(4-methoxycyclohexyl)-1h-benzo[d]imidazol-2-yl)piperidin-2-one
35. Jhl
| Molecular Weight | 534.6 g/mol |
|---|---|
| Molecular Formula | C30H32F2N4O3 |
| XLogP3 | 4.9 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 7 |
| Rotatable Bond Count | 5 |
| Exact Mass | 534.24424722 g/mol |
| Monoisotopic Mass | 534.24424722 g/mol |
| Topological Polar Surface Area | 73.4 Ų |
| Heavy Atom Count | 39 |
| Formal Charge | 0 |
| Complexity | 860 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 1 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
Drugs in Development
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]Digital Content
NEWS #PharmaBuzz
ABOUT THIS PAGE
A Inobrodib manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Inobrodib, including repackagers and relabelers. The FDA regulates Inobrodib manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Inobrodib API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Inobrodib supplier is an individual or a company that provides Inobrodib active pharmaceutical ingredient (API) or Inobrodib finished formulations upon request. The Inobrodib suppliers may include Inobrodib API manufacturers, exporters, distributors and traders.
Inobrodib Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Inobrodib GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Inobrodib GMP manufacturer or Inobrodib GMP API supplier for your needs.
A Inobrodib CoA (Certificate of Analysis) is a formal document that attests to Inobrodib's compliance with Inobrodib specifications and serves as a tool for batch-level quality control.
Inobrodib CoA mostly includes findings from lab analyses of a specific batch. For each Inobrodib CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Inobrodib may be tested according to a variety of international standards, such as European Pharmacopoeia (Inobrodib EP), Inobrodib JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Inobrodib USP).
LOOKING FOR A SUPPLIER?
